Skip to main content
logo
Outlook Therapeutics, Inc. (OTLK)
NASDAQ: OTLK · Real-Time Price · USD
0.4046
-0.0248 (-5.78%)
At close: Feb 9, 2026, 4:00 PM EST
0.4023
-0.0023 (-0.57%)
After-hours: Feb 9, 2026, 7:45 PM EST

Outlook Therapeutics Income Statement

Millions USD. Fiscal year is Oct - Sep.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '25 Sep '24 Sep '23 Sep '22 Sep '21
Revenue
1.41----
Cost of Revenue
28.5441.7626.4542.3338.96
Gross Profit
-27.12-41.76-26.45-42.33-38.96
Selling, General & Admin
39.9429.9426.6720.7412.77
Operating Expenses
39.9429.9426.6720.7412.77
Operating Income
-67.06-71.7-53.13-63.07-51.73
Interest Expense
-0.28-3.16-2.53-1.49-0.94
Interest & Investment Income
0.090.910.97--
Earnings From Equity Investments
-0.14-0.1-0.01-0.05-0.05
Other Non Operating Income (Expenses)
9.491.150.050.47-0.45
EBT Excluding Unusual Items
-57.9-72.91-54.65-64.14-53.16
Other Unusual Items
-6.07-2.46-4.33-1.91-
Pretax Income
-63.98-75.36-58.98-66.05-53.16
Income Tax Expense
-1.550000
Earnings From Continuing Operations
-62.42-75.37-58.98-66.05-53.16
Net Income
-62.42-75.37-58.98-66.05-53.16
Net Income to Common
-62.42-75.37-58.98-66.05-53.16
Shares Outstanding (Basic)
351913118
Shares Outstanding (Diluted)
351913118
Shares Change (YoY)
87.59%48.29%17.96%38.91%110.43%
EPS (Basic)
-1.79-4.06-4.72-6.23-6.96
EPS (Diluted)
-1.79-4.06-4.72-6.23-6.96
Free Cash Flow
-51.83-68.79-42.97-56.67-54.25
Free Cash Flow Per Share
-1.49-3.71-3.44-5.34-7.11
Operating Margin
-4744.25%----
Profit Margin
-4416.22%----
Free Cash Flow Margin
-3666.65%----
EBITDA
-66.94-71.59-53.08-62.87-51.46
D&A For EBITDA
0.120.110.040.20.26
EBIT
-67.06-71.7-53.13-63.07-51.73
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q